Utilization of real‐world data in assessing treatment effectiveness for diffuse large B‐cell lymphoma

Direct comparisons of the effectiveness of the numerous novel therapies in the diffuse large B‐cell lymphoma (DLBCL) treatment landscape in a range of head‐to‐head randomized phase 3 trials would be time‐consuming and costly. Comparative effectiveness studies using real‐world data (RWD) represent a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowakowski, Grzegorz, Maurer, Matthew J., Cerhan, James R., Dey, Debarshi, Sehn, Laurie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Critical Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092365/
https://www.ncbi.nlm.nih.gov/pubmed/36251361
http://dx.doi.org/10.1002/ajh.26767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092365/
https://www.ncbi.nlm.nih.gov/pubmed/36251361
http://dx.doi.org/10.1002/ajh.26767

Ejemplares similares